The significance of the site of recurrence to subsequent breast cancer survival

	Tweet

The 3-year survival of patients with recurrent breast cancer was determined; the prognosis was progressively worse with local, regional, bone, and visceral metastases

The study was a review of 294 patients from a breast cancer database, who were treated for operable breast cancer and subsequently developed a recurrence between 1989 and 2003. Patients were divided into four groups according to the site of first recurrence (local, lymph node, bone or visceral). Breast Cancer Specific Survival (BCSS) was compared using Kaplan–Meier life table analysis and the log rank test.

Methodology

* A retrospective review was conducted involving 294 patients with recurrent breast cancer between 1989 and 2003
* Breast cancer recurrences were categorized as local, regional, bone, and visceral metastases

Results

* Three-year breast cancer specific survivals were 83% for local recurrence as compared with 33% for lymph node, 23% for bone, and 13% for visceral recurrences

A. Imkampe S. Bendall and T. Bates
The Breast Unit, William Harvey Hospital, Ashford, Kent TN24 0LZ, UK
Accepted 6 September 2006.  Available online 16 October 2006.
ScienceDirect
more

RELATED STORIES:
Experimental Agent Reduces Breast Cancer Metastasis to Bone   A novel therapeutic target to slow breast cancer cell motility   Pregnancy cuts breast cancer in mutation carriers   Pioneering Breast Scanner Holds Promise for Detecting, Diagnosing Cancer Earlier   Breast cancer cells recycle to escape death by hormonal therapy   Princeton scientists discover mechanism involved in breast cancer’s spread to bone   Manchester researchers announce new methods of beating breast cancer   An earlier start on diagnosing breast, prostate cancers   ‘Microtentacles’ on tumor cells appear to play role in how breast cancer spreads   Australian scientists plan to regrow breasts after cancer   Delays in Radiation Therapy Lead to Increased Breast Cancer Recurrence   Breast Cancer Patients with BRCA Mutations at 4x Higher Risk for Contralateral Breast Cancer   Ultrasound Plus Mammography May Improve Breast Cancer Detection   Genes interact to affect breast cancer survival   New breast cancer drug Femara will save lives   Study determines costs of breast and cervical cancer detection among low-income women   Heart drug linked to higher breast cancer risk   Active women with breast cancer may live longer   Breast Self-Exams Do Not Appear to Reduce Breast Cancer Deaths   Study Suggests Mastectomy Not Being Overused For Breast Cancer Treatment   Full Field Digital Mammography: A New Breast Cancer Screening Tool   UC Davis researchers use heated nanoprobes to destroy breast cancer cells in mice

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]